Shares of Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) were up 1.6% during mid-day trading on Tuesday . The company traded as high as $0.64 and last traded at $0.64. Approximately 1,200 shares traded hands during trading, a decline of 7% from the average daily volume of 1,288 shares. The stock had previously closed at $0.63.
Starpharma Trading Up 1.6 %
The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.58 and a current ratio of 4.94. The company’s 50 day moving average price is $0.70 and its 200 day moving average price is $0.69.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Further Reading
- Five stocks we like better than Starpharma
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Election Stocks: How Elections Affect the Stock Market
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How to Short Nasdaq: An Easy-to-Follow Guide
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
